–
April 20, 2022
Dr. Francis Szoka focuses on improving gene, recombinant protein and drug delivery using biophysical, molecular biology and chemical approaches. He and his team have applied biophysical approaches to create methods and tools that are now widely used to manufacture liposomes, polyplexes and lipoplexes. They have extensively investigated the mechanisms of non-viral gene delivery. Their recent efforts in the treatment of cancer involves the design and synthesis of prodrugs and the generation of amorphous nanosized drug particles to improve the bioavailability of sparingly soluble anticancer drugs.